Acme Generics (Oral Solid Formulations Business) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Acme Generics (Oral Solid Formulations Business) General Information

Description

Manufacturer of oral solid pharmaceutical formulations intended for global drug companies. The company operates USFDA-approved manufacturing facilities specialized in thyroid products, enabling pharmaceutical companies to access integrated contract development and manufacturing services for complex oral solid medicines across international markets.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Corporate Office
  • India
Primary Industry
Pharmaceuticals
Acquirer
BDR Pharmaceuticals Internationals
Vertical(s)
Manufacturing
Corporate Office
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acme Generics (Oral Solid Formulations Business) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acme Generics (Oral Solid Formulations Business)‘s full profile, request access.

Request a free trial

Acme Generics (Oral Solid Formulations Business) FAQs

  • Where is Acme Generics (Oral Solid Formulations Business) headquartered?

    Acme Generics (Oral Solid Formulations Business) is headquartered in India.

  • What industry is Acme Generics (Oral Solid Formulations Business) in?

    Acme Generics (Oral Solid Formulations Business)’s primary industry is Pharmaceuticals.

  • Is Acme Generics (Oral Solid Formulations Business) a private or public company?

    Acme Generics (Oral Solid Formulations Business) is a Private company.

  • What is Acme Generics (Oral Solid Formulations Business)’s current revenue?

    The current revenue for Acme Generics (Oral Solid Formulations Business) is .

  • When was Acme Generics (Oral Solid Formulations Business) acquired?

    Acme Generics (Oral Solid Formulations Business) was acquired on 09-Nov-2026.

  • Who acquired Acme Generics (Oral Solid Formulations Business)?

    Acme Generics (Oral Solid Formulations Business) was acquired by BDR Pharmaceuticals Internationals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process